Using Dr. Janice M. Johnson’s extensive knowledge, experience, and success, the Johnson advantEDge Institute provides development and optimization services for chemically-defined cell culture medium to enhance the production of monoclonal antibodies for use as therapeutics.
In addition to being a business performance expert, Dr. Johnson is an innovative & results-oriented biological scientist in the medical devices and biotechnology industries. Dr. Johnson uses her sound analytical & problem-solving abilities to improve the productivity and manufacturing processes of biologics for Fortune 500 and international companies like Bayer, Biomarin, Xoma, and Johnson & Johnson through the optimization of chemically-defined cell culture medium. Dr. Johnson has also successfully developed the IS CHO-CD™, IS PRO-VEC™, and EX-CELL™ NS0 commercially-available cell culture media products in record times for Fuji (formerly Irvine Scientific), Sigma-Aldrich (formerly JRH Biosciences), and Lonza ( formerly BioWhittaker and Cambrex).
References
Janice M. Johnson holds M.S. and B.S. degrees in Biology from Louisiana Tech University, and a Ph.D. in Organization and Management from Capella University.
Contact us to learn more about partnership opportunities for the optimization of chemically-defined cell culture medium that specifically increases your antibody and protein yield.
